- Home
- / DarioHealth
DarioHealth
Stock Price
$3.2
2023-09-28
Market Capitalization
$88 M
2023-09-28
Revenue
$27.7 M
FY, 2022
DarioHealth Summary
Company Summary
- Overview
- DarioHealth is a digital therapeutics company that provides chronic condition management solutions. It develops disposables test strip cartridges, lancets, and blood glucose monitoring systems. The company offers diabetes care, musculoskeletal, evidence-based mental health care, remote patient monitoring solutions, etc.
- Type
- Public
- Status
- Active
- Founded
- 2011
- HQ
- New York, NY, US | view all locations
- Website
- https://www.dariohealth.com
- Cybersecurity rating
Table of Contents
Key People
Rick Anderson, President & GM US
Jerrod Helms, Chief Commercial Officer
Omar Manejwala, Chief Medical Officer
LocationsView all
3 locations detected
New York, NY HQ
United States
18 W 18th St
New York, NY
United States
142 W 57th St 8th floor
Caesarea, Haifa District
Israel
8 Ha-Tokhen St
DarioHealth Financials
Summary Financials
- Revenue (Q2, 2023)
- $6.2M
- Gross profit (Q2, 2023)
- $2.1M
- Net income (Q2, 2023)
- ($16.6M)
- Cash (Q2, 2023)
- $52.6M
- EBIT (Q2, 2023)
- ($14.0M)
- Enterprise value
- $64.6M